A Phase 4 interventional study of Articaine 4%/Epi 1:100000 Inj Cart 1.7Ml and Lidocaine 2%/Epi 1:100000 Inj Cart 1.7Ml in Pain, sponsored by Riyadh Elm University. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-08.
Sponsored by Riyadh Elm University · Phase 4, Interventional, and Treatment
The goal of this clinical trial, is to test out the efficacy of using Articaine only as a local anesthesia as buccal infiltration to extract lower molar teeth.
Study will be performed in patients visiting Riyadh Elm University clinics seeking extraction of lower molars bilaterally, in each visit one molar tooth will be extracted using Ariticaine and the second visit with Lidocaine, pain level will be monitored and documented.
This study may be helpful in providing scientific information to the oral maxillofacial surgeons which will assist them in choosing the best local anesthetic agent, and possibly substituting using inferior alveolar nerve block with infiltration only when extracting the mandibular posterior teeth.
This is a double-blind, randomized clinical trial, which will involve 40 patients visiting the out-patient department of Oral and Maxillofacial surgery. For each patient, one mandibular molar will be extracted from right as well as left side, with one side being anesthetized using 4% articaine with 1:100,000 epinephrine and other with 2% lidocaine with 1:100,000 epinephrine buccal infiltration only. Evaluation and comparison will be done on the basis of pain prevalence exhibited by the patients while extraction.
Riyadh Elm University is the lead sponsor of 24 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Articaine 4% with 1:100,000 epinephrine
Drug: Articaine 4%/Epi 1:100000 Inj Cart 1.7Ml
Lidocaine 2% with 1:100,000
Drug: Lidocaine 2%/Epi 1:100000 Inj Cart 1.7Ml
4% articaine with 1:100,000 epinephrine buccal infiltration
Also known as: Septanest
2% Lidocaine with 1:100,000 epinephrine buccal infiltration
Also known as: Octocaine
Pain measurement
Pain will be measured using the vial analogue scale
Time frame: Pain will be measured after injection, during extraction procedure and at the end of the session immediately after finishing the procedure, scale of pain will be 0 for no pain and 10 for maximum pain
No study locations are listed for this record.
Plan to share: No
This study is not yet recruiting, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Riyadh Elm University